Eosinophilic bronchiolitis successfully treated with mepolizumab.

Takeshita, Yuichiro; Nobuyama, Seiichi; Kanetsuna, Yukiko; Tanaka, Akihiko; Adachi, Mitsuru; Sato, Tetsuo; Tada, Yuji

Takeshita, Yuichiro; Nobuyama, Seiichi; Kanetsuna, Yukiko; Tanaka, Akihiko; Adachi, Mitsuru; Sato, Tetsuo; Tada, Yuji.

Afiliação

Takeshita Y; Department of Respiratory Medicine, International University of Health and Welfare, Atami Hospital, Atami, Shizuoka, Japan.
Nobuyama S; Department of Respiratory Medicine, Kansai Medical University, Osaka, Japan.
Kanetsuna Y; Department of Pathology, International University of Health and Welfare, Atami Hospital, Atami, Shizuoka, Japan.
Tanaka A; Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
Adachi M; Clinical Research Center, International University of Health and Welfare, Sanno Hospital, Tokyo, Japan.
Sato T; Department of Respiratory Medicine, International University of Health and Welfare, Atami Hospital, Atami, Shizuoka, Japan.
Tada Y; Department of Respiratory Medicine, International University of Health and Welfare, Atami Hospital, Atami, Shizuoka, Japan. Electronic address: ytada25@yahoo.co.jp.

J Allergy Clin Immunol Pract ; 8(3): 1159-1161.e1, 2020 Mar.

Article em En | MEDLINE | ID: mdl-31678294

Assuntos

Antiasmáticos; Bronquiolite; Anticorpos Monoclonais Humanizados/uso terapêutico; Bronquiolite/diagnóstico; Bronquiolite/tratamento farmacológico; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquiolite / Antiasmáticos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google